Endometrial Cancer: Symptoms, Diagnosis, Treatment, and Care at Apollo Hospitals

Endometrial cancer begins in the lining of the uterus (the endometrium). It is the most common gynecologic cancer in many countries and is often detected early because it frequently causes abnormal uterine bleeding—an early warning sign that prompts evaluation. When found early, endometrial cancer is highly treatable, and many people are cured. This comprehensive article explains what endometrial cancer is, who it affects, what symptoms to watch for, how it is diagnosed and staged, modern treatments, recovery, and prevention strategies so informed, confident decisions are easier at every step.

Note: This guide is educational and does not replace medical advice. Individual care should be guided by a qualified gynecologic oncology team.

Overview: What Is Endometrial Cancer and Why Early Detection Matters

Endometrial cancer starts in the lining of the uterus (called the endometrium). The cells in this lining grow in an uncontrolled way and may form a tumor. Because the endometrium sheds as menstrual blood, changes in the lining often cause irregular bleeding—an early symptom that leads to testing.

Why early detection matters:

• Many cases are diagnosed at Stage I, when the cancer is confined to the uterus and highly curable.
• Prompt evaluation of abnormal bleeding can lead to simpler treatments, shorter recovery, and better outcomes.
• Early detection enables fertility-sparing options for carefully selected patients who wish to preserve childbearing.

How common is it?

• Endometrial (uterine) cancer is the most common gynecologic cancer in many regions.
• It is most often diagnosed after menopause, but it can occur earlier, especially in people with specific risk factors such as obesity or polycystic ovary syndrome (PCOS).

Types of Endometrial Cancer

Doctors classify endometrial cancer by how the cells look under a microscope and by the tumor’s molecular features. This classification helps guide treatment and prognosis.

Endometrioid adenocarcinoma (Type I)

• The most common subtype.
• Often linked to estrogen-driven growth.
• Usually diagnosed at an early stage and associated with favorable outcomes.

Non-endometrioid subtypes (Type II)

• Serous, clear cell, carcinosarcoma (malignant mixed Müllerian tumor), and others.
• Less common but often more aggressive; can be diagnosed at higher stages.
• Managed with comprehensive treatment plans and closer follow-up.

Molecular classification (increasingly used)

• POLE-ultramutated, MSI-high (mismatch repair-deficient), copy-number low, and copy-number high (p53-abnormal).
• These categories help tailor treatment (for example, treatments that help the body’s immune system fight the cancer in MSI-high tumors).

Precancerous changes

Endometrial hyperplasia (with or without atypia) can precede cancer. Atypical hyperplasia (also called endometrial intraepithelial neoplasia) requires treatment and careful follow-up.

Causes: What Leads to Endometrial Cancer?

Endometrial cancer often develops when the endometrium is exposed to estrogen without enough progesterone to balance it. This “”unopposed estrogen”” can stimulate the lining to grow excessively, increasing cancer risk. Additional contributors include:

• Hormonal factors (estrogen exposure without progesterone, early menarche or late menopause).
• Obesity and metabolic changes (higher estrogen levels from body fat).
• Insulin resistance and chronic inflammation (as in some cases of PCOS).
• Genetic predisposition (e.g., Lynch syndrome).
• Prior pelvic radiation (less common).
• Tamoxifen therapy (used for breast cancer) slightly increases risk; benefits and risks are weighed carefully.

Most people with endometrial cancer have multiple influences rather than a single cause.

Risk Factors: Who Is at Higher Risk?

A risk factor increases the chance of developing cancer; it does not make it certain.

Age

Most cases occur after menopause, but risk begins to rise in the 40s and 50s.

Hormonal and reproductive factors

• Long periods of unopposed estrogen (no progesterone), such as irregular ovulation in PCOS.
• Never having given birth.
• Early first period (menarche) or late menopause.
• Estrogen-only hormone therapy after menopause (without progesterone).

Metabolic and lifestyle factors

• Obesity (a strong and modifiable risk factor).
• Type 2 diabetes, insulin resistance, and lack of physical activity.
• High-fat, low-fiber diet.

Medical treatments and conditions

• Tamoxifen use (small increase in risk).
• Prior pelvic radiation.

Genetic predisposition

• Lynch syndrome (hereditary nonpolyposis colorectal cancer) significantly increases risk.
• Family history of colorectal, endometrial, or ovarian cancers may indicate an inherited syndrome.

Discuss personal risk with a clinician; many risks can be reduced with targeted lifestyle and medical strategies.

What Are the Symptoms of Endometrial Cancer?

Early symptoms are common and should be evaluated promptly—especially after menopause.

Common early signs:

• Abnormal uterine bleeding:
  • Any bleeding after menopause.
  • Bleeding between periods or unusually heavy, prolonged periods.
  • Watery, pink, or brown vaginal discharge.
  • Spotting after sex.

Advanced symptoms:

• Pelvic pain or pressure.
• Pain during sex.
• Unintentional weight loss, fatigue, or changes in bowel or bladder habits.
• Anemia-related symptoms (fatigue, shortness of breath) from chronic blood loss.

Any bleeding after menopause should be checked by a doctor. For younger women, heavy or unusual bleeding that doesn’t settle also needs medical attention.

How Is Endometrial Cancer Diagnosed?

Doctors use a combination of exam, imaging, and tissue sampling to confirm the diagnosis and plan treatment.

Medical history and pelvic exam

Review of bleeding patterns, periods, medical conditions, medications, and family history. Pelvic exam to assess the uterus, cervix, and surrounding areas (ovaries, tubes).

Transvaginal ultrasound

Measures endometrial thickness and evaluates the uterus and ovaries. Thickened lining after menopause often prompts biopsy.

Endometrial biopsy (key step)

A thin tube is used in the clinic to gently sample the lining for pathology. Often confirms or rules out cancer or precancer. If the biopsy does not give a clear answer, doctors may do a small procedure called a hysteroscopy (using a camera to see inside the uterus) with gentle scraping (D&C) to get more tissue for testing.

Imaging for staging and planning (after cancer is diagnosed)

• MRI pelvis to assess depth of invasion into the muscle wall and possible cervical involvement.
• CT scan of the chest/abdomen/pelvis to evaluate lymph nodes and distant spread.
• PET-CT is considered in selected scenarios for comprehensive staging.

Laboratory tests

Blood counts (to check for anemia), kidney and liver function. Genetic testing for Lynch syndrome may be recommended, particularly in younger patients or those with suggestive family history.

Together, these steps confirm the diagnosis and help tailor a precise, personalized treatment plan.

Staging and Grading: What They Mean

Endometrial cancer is staged surgically in most cases, based on findings at the time of hysterectomy and lymph node assessment.

FIGO staging (simplified)

• Stage I: Confined to the uterus (IA: superficial muscle invasion; IB: deeper invasion).
• Stage II: Involves the cervix.
• Stage III: Spread to the surrounding areas (ovaries/tubes), vagina, supporting tissues, or regional lymph nodes.
• Stage IV: The cancer has spread outside the uterus to nearby organs like the bladder or rectum, or to distant places such as the lungs, liver, or bones.

Grading (how abnormal the cells look)

• Grade 1: Well-differentiated (low grade).
• Grade 2: Moderately differentiated.
• Grade 3: Poorly differentiated (high grade).

Why it matters:

Stage and grade guide the need for lymph node mapping, radiation, chemotherapy, or combinations. Molecular features (e.g., mismatch repair status, p53) increasingly inform treatment choices after surgery and the role of treatments that help the body’s immune system fight the cancer in advanced disease. Fertility-sparing decisions rely heavily on grade, stage, and molecular results.

Treatment Options for Endometrial Cancer

Treatment is individualized by stage, grade, molecular profile, age, overall health, and fertility goals. A multidisciplinary team—gynecologic oncologists, radiation oncologists, medical oncologists, radiologists, pathologists, fertility experts, physical therapists, nutritionists, and psychosocial support professionals—works together to optimize outcomes and quality of life.

Surgery

Surgery is the cornerstone for most early-stage cases.

Standard procedure

• Total hysterectomy (removal of the uterus and cervix).
• Most women will also have the ovaries and fallopian tubes removed during surgery, especially after menopause. In younger women, the decision depends on risk and individual preferences.

Lymph node assessment

• Sentinel lymph node mapping or removal of pelvic and higher lymph nodes to check for spread.
• Minimally invasive (laparoscopic or robotic) approaches are common, with faster recovery and less pain for suitable candidates.

Fertility-sparing management (very select cases)

For carefully chosen patients with Grade 1, Stage IA (no muscle invasion) disease who strongly desire future fertility: In selected young women with very early, low-grade cancer who want to have children in the future, doctors may try hormone therapy (tablets or a hormone-releasing device inside the uterus). This needs strict follow-up with repeat biopsies. Requires strict follow-up and readiness to convert to standard surgery if disease persists or progresses. Not appropriate for higher-grade or invasive tumors.

Recovery and rehabilitation

Most minimally invasive surgeries allow discharge within 1-2 days. Light activity resumes within days; full recovery typically in 2-4 weeks (longer for open surgery). Pelvic floor therapy and gentle exercise support healing and function.

Medical Treatment

Hormone therapy (progestins)

Beneficial in:

• Fertility-sparing management (as above).
• Advanced or recurrent hormone-sensitive tumors.

Options include oral progestins, levonorgestrel-releasing intrauterine device (IUD), or combined approaches.

Chemotherapy

Used for higher-risk, advanced-stage, or recurrent disease. Often includes platinum-based regimens (e.g., carboplatin) with a partnering drug (e.g., paclitaxel). Side effects can include fatigue, nausea, hair loss, and lowered blood counts; modern supportive care reduces risks and improves comfort.

Targeted therapy

Used in specific settings:

• Anti-angiogenic agents that limit blood supply to tumors.
• Agents targeting certain molecular alterations (select cases).
• Treatments that help the body’s immune system fight the cancer, particularly effective in mismatch repair-deficient (MSI-high) or POLE-ultramutated tumors.
• Advanced and recurrent cancers.
• Immune checkpoint inhibitors can control disease and may be combined with other therapies in advanced or recurrent settings.

Side effects involve immune-related inflammation (skin, bowel, liver, endocrine), typically manageable with prompt, expert care.

Supportive and integrative care

Antiemetics, pain control, nutritional support, physical therapy, and psychosocial counseling. Management of menopause symptoms after ovary removal and bone health support as needed.

Radiation Therapy

Radiation is used to reduce the risk of local recurrence and to treat advanced or inoperable disease.

Vaginal brachytherapy (internal radiation)

Internal radiation (brachytherapy) delivers radiation directly to the top of the vagina, where cancer may come back. It is usually done as a short outpatient procedure, with little recovery time needed. Often used after surgery in early-stage, higher-risk patients.

External beam radiation therapy (EBRT)

Targets the pelvis (and higher lymph nodes if needed) to treat involved areas or reduce recurrence risk. Advanced techniques (IMRT/IGRT) shape the dose to spare bowel, bladder, and bone marrow.

Palliative radiation

Helps relieve symptoms such as pain or bleeding in advanced disease.

Proton Therapy

Proton therapy delivers a precise dose with limited exit radiation, potentially reducing exposure to nearby healthy tissues. May be considered in:

• Re-irradiation scenarios where prior radiation limits safety.
• Complex anatomy where sparing bowel, bladder, kidneys, spinal cord, or bone marrow is especially important.

Traditional, expertly planned photon radiation (IMRT/IGRT) is effective for most cases; suitability of protons is considered individually.

Prognosis: Survival, Outcomes, and What Affects Them

Most women with early-stage endometrial cancer do very well and can return to normal, active lives after treatment. Outcomes depend on:

• Stage at diagnosis (depth of invasion, lymph node status).
• Grade and histology (endometrioid vs serous/clear cell/carcinosarcoma).
• Molecular features (e.g., MSI-high or POLE-ultramutated tumors often have favorable responses to modern therapies).
• Surgical completeness and the need for adjuvant therapy.
• Overall health, body weight, metabolic health, and adherence to follow-up.

Screening and Prevention: Protecting Uterine Health

Know the warning sign

Any bleeding after menopause is abnormal and should be evaluated. Report persistent heavy or irregular bleeding at any age.

Maintain a healthy weight

Weight loss (if needed), regular physical activity, and a balanced diet reduce risk.

Manage metabolic health

Control of diabetes and insulin resistance. Treat PCOS and menstrual irregularities to reduce prolonged unopposed estrogen exposure.

Discuss hormone therapy carefully

If you take hormone replacement therapy after menopause, it is important to take both estrogen and progesterone (if you still have your uterus). This reduces cancer risk.

Genetic counseling

If there is a strong family history of colon, endometrial, or ovarian cancer—or known Lynch syndrome—genetic counseling and tailored surveillance are recommended.

Follow-up after precancer

After treatment of endometrial hyperplasia with atypia, close surveillance and definitive surgery (when advised) reduce cancer risk.

For International Patients: Seamless Access and Support at Apollo

Apollo Hospitals provides comprehensive, coordinated care for international patients:

Pre-arrival medical review

Secure sharing of reports for a preliminary opinion and tentatively tailored plan.

Appointment and treatment coordination

Priority scheduling with gynecologic oncology, radiation oncology, medical oncology, radiology, pathology, fertility counseling (where relevant), nutrition, physiotherapy, and supportive care.

Travel and logistics

Assistance with medical visa invitations, airport pickup on request, nearby accommodations, and local transportation guidance.

Language and cultural support

Interpreter services, patient navigators, and clear written care plans for comfort and confidence.

Financial counseling

Transparent estimates, package options when feasible, and support with international payments and insurance coordination.

Continuity of care

Detailed discharge summaries, survivorship plans (including menopause and bone health counseling), and teleconsultations, with coordination for care in the home country.

Recovery, Side Effects, and Follow-Up: What to Expect

During treatment

Side effects depend on the specific treatments but may include surgical recovery, menopause symptoms if ovaries are removed, fatigue from radiation or chemotherapy. The care team provides supportive medicines and strategies to manage symptoms.

After surgery

Most return to normal activities within weeks; full recovery varies by procedure type. Hormone replacement therapy may be discussed if ovaries are removed.

After radiation or chemotherapy

Side effects typically improve over weeks to months after treatment ends. Long-term care may include managing vaginal changes and bone health.

Long-term survivorship

Regular check-ups monitor for recurrence and late effects. Support for quality of life, including sexual health and emotional well-being.

Follow-up schedule

Frequent visits initially (every 3-4 months), then gradually less often. Pelvic exams, symptom review, and imaging as recommended.

Why Choose Apollo Hospitals for Endometrial Cancer Care

• Comprehensive gynecologic oncology team with expertise in all stages of endometrial cancer.
• Advanced surgical options including minimally invasive and fertility-sparing techniques.
• State-of-the-art radiation therapy including IMRT/IGRT and brachytherapy.
• Full range of systemic therapies including targeted and immune-based treatments.
• Integrated supportive care including fertility counseling, menopause management, and rehabilitation.
• International patient coordination with transparent estimates and comprehensive support.

Next Steps

• Seek a gynecologic evaluation for any abnormal bleeding, especially after menopause.
• If diagnosed, request a multidisciplinary consultation to discuss surgical approach, need for lymph node assessment, and potential adjuvant therapy based on pathology and molecular features.
• Ask about recovery time, sexual health and vaginal care after treatment, bone health if ovaries are removed, and an individualized follow-up plan.
• Keep a written list of questions and bring prior test results to streamline planning.

With timely diagnosis, evidence-based treatment, and compassionate, coordinated care, most people with endometrial abnormalities or early endometrial cancer do very well. Awareness of the key symptom—abnormal bleeding—combined with healthy lifestyle choices and prompt medical attention, provides powerful protection and a strong foundation for long-term wellness.